Engineering of bacteria for the visualization of targeted delivery of a cytolytic anticancer agent

Molecular Therapy

Volumn 21, Issue 11, 2013, Pages 1985-1995

  Jiang, Sheng Nan ^a,b,c   Park, Seung Hwan ^a   Lee, Hee Jung ^a,d   Zheng, Jin Hai ^a   Kim, Hyung Seok ^b   Bom, Hee Seung ^b   Hong, Yeongjin ^b   Szardenings, Michael ^e   Shin, Myung Geun ^b   Kim, Sun Chang ^f   Ntziachristos, Vasilis ^g   Choy, Hyon E ^b   Min, Jung Joon ^a,b  

^a Chonnam National University   (South Korea)

^b Chonnam National University Medical School   (South Korea)

^c CENTRAL SOUTH UNIVERSITY   (China)

^d Green Cross Company   (South Korea)

^e FRAUNHOFER INSTITUTE FOR CELL THERAPY AND IMMUNOLOGY   (Germany)

^f Korea Advanced Institute of Science and Technology (KAIST)   (South Korea)

^g TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; BACTERIAL PROTEIN; CYTOLYSIN A; DOXYCYCLINE; TETRACYCLINE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL GENE; BIOLUMINESCENCE; CANCER INHIBITION; CANCER TISSUE; CONTROLLED STUDY; DOSE RESPONSE; DRUG DELIVERY SYSTEM; GENE EXPRESSION; HUMAN; HUMAN CELL; LIVER INJURY; LUNG METASTASIS; MALE; METASTASIS; MOUSE; NONHUMAN; PLASMID; PRIMARY TUMOR; PROMOTER REGION; REPORTER GENE; SALMONELLA TYPHIMURIUM; SPLEEN INJURY; SURVIVAL TIME;

BACTERIA (MICROORGANISMS); MUS; RENILLA LUCIFERASE; SALMONELLA; SALMONELLA TYPHIMURIUM;

ANIMALS; CELL LINE, TUMOR; DOXYCYCLINE; GENES, REPORTER; GENETIC ENGINEERING; GENETIC THERAPY; HUMANS; LUMINESCENT MEASUREMENTS; LUNG NEOPLASMS; MALE; MICE; MICE, INBRED BALB C; NEOPLASM METASTASIS; PERFORIN; PROMOTER REGIONS, GENETIC; SALMONELLA TYPHIMURIUM;

EID: 84887433850     PISSN: 15250016     EISSN: 15250024     Source Type: Journal    
DOI: 10.1038/mt.2013.183     Document Type: Article

References (49)

1. Min, JJ, Kim, HJ, Park, JH, Moon, S, Jeong, JH, Hong, YJ et al. (2008). Noninvasive real-time imaging of tumors and metastases using tumor-targeting light-emitting Escherichia coli. Mol Imaging Biol 10: 54-61.
2. Min, JJ, Nguyen, VH, Kim, HJ, Hong, Y and Choy, HE (2008). Quantitative bioluminescence imaging of tumor-targeting bacteria in living animals. Nat Protoc 3: 629-636.
3. Yu, YA, Shabahang, S, Timiryasova, TM, Zhang, Q, Beltz, R, Gentschev, I et al. (2004). Visualization of tumors and metastases in live animals with bacteria and vaccinia virus encoding light-emitting proteins. Nat Biotechnol 22: 313-320.
4. Jiang, SN, Phan, TX, Nam, TK, Nguyen, VH, Kim, HS, Bom, HS et al. (2010). Inhibition of tumor growth and metastasis by a combination of Escherichia coli-mediated cytolytic therapy and radiotherapy. Mol Ther 18: 635-642.
5. Weibel, S, Stritzker, J, Eck, M, Goebel, W and Szalay, AA (2008). Colonization of experimental murine breast tumours by Escherichia coli K-12 significantly alters the tumour microenvironment. Cell Microbiol 10: 1235-1248.
6. Low, KB, Ittensohn, M, Le, T, Platt, J, Sodi, S, Amoss, M et al. (1999). Lipid A mutant Salmonella with suppressed virulence and TNFalpha induction retain tumor-targeting in vivo. Nat Biotechnol 17: 37-41.
7. Pawelek, JM, Low, KB and Bermudes, D (2003). Bacteria as tumour-targeting vectors. Lancet Oncol 4: 548-556.
8. Zhao, M, Yang, M, Li, XM, Jiang, P, Baranov, E, Li, S et al. (2005). Tumor-targeting bacterial therapy with amino acid auxotrophs of GFP-expressing Salmonella typhimurium. Proc Natl Acad Sci USA 102: 755-760.
9. Agrawal, N, Bettegowda, C, Cheong, I, Geschwind, JF, Drake, CG, Hipkiss, EL et al. (2004). Bacteriolytic therapy can generate a potent immune response against experimental tumors. Proc Natl Acad Sci USA 101: 15172-15177.
10. Dang, LH, Bettegowda, C, Huso, DL, Kinzler, KW and Vogelstein, B (2001). Combination bacteriolytic therapy for the treatment of experimental tumors. Proc Natl Acad Sci USA 98: 15155-15160.
11. Kohwi, Y, Imai, K, Tamura, Z and Hashimoto, Y (1978). Antitumor effect of Bifidobacterium infantis in mice. Gann 69: 613-618.
12. Akin, D, Sturgis, J, Ragheb, K, Sherman, D, Burkholder, K, Robinson, JP et al. (2007). Bacteria-mediated delivery of nanoparticles and cargo into cells. Nat Nanotechnol 2: 441-449.
13. Zhao, M, Yang, M, Ma, H, Li, X, Tan, X, Li, S et al. (2006). Targeted therapy with a Salmonella typhimurium leucine-arginine auxotroph cures orthotopic human breast tumors in nude mice. Cancer Res 66: 7647-7652.
14. Toso, JF, Gill, VJ, Hwu, P, Marincola, FM, Restifo, NP, Schwartzentruber, DJ et al. (2002). Phase I study of the intravenous administration of attenuated Salmonella typhimurium to patients with metastatic melanoma. J Clin Oncol 20: 142-152.
15. Zhao, M, Geller, J, Ma, H, Yang, M, Penman, S and Hoffman, RM (2007). Monotherapy with a tumor-targeting mutant of Salmonella typhimurium cures orthotopic metastatic mouse models of human prostate cancer. Proc Natl Acad Sci USA 104: 10170-10174.
16. Hayashi, K, Zhao, M, Yamauchi, K, Yamamoto, N, Tsuchiya, H, Tomita, K et al. (2009). Systemic targeting of primary bone tumor and lung metastasis of high-grade osteosarcoma in nude mice with a tumor-selective strain of Salmonella typhimurium. Cell Cycle 8: 870-875.
17. Hayashi, K, Zhao, M, Yamauchi, K, Yamamoto, N, Tsuchiya, H, Tomita, K et al. (2009). Cancer metastasis directly eradicated by targeted therapy with a modified Salmonella typhimurium. J Cell Biochem 106: 992-998.
18. Yam, C, Zhao, M, Hayashi, K, Ma, H, Kishimoto, H, McElroy, M et al. (2010). Monotherapy with a tumor-targeting mutant of S. typhimurium inhibits liver metastasis in a mouse model of pancreatic cancer. J Surg Res 164: 248-255.
19. Momiyama, M, Zhao, M, Kimura, H, Tran, B, Chishima, T, Bouvet, M et al. (2012). Inhibition and eradication of human glioma with tumor-targeting Salmonella typhimurium in an orthotopic nude-mouse model. Cell Cycle 11: 628-632.
20. Nguyen, VH, Kim, HS, Ha, JM, Hong, Y, Choy, HE and Min, JJ (2010). Genetically engineered Salmonella typhimurium as an imageable therapeutic probe for cancer. Cancer Res 70: 18-23.
21. Loeffler, M, Le'Negrate, G, Krajewska, M and Reed, JC (2007). Attenuated Salmonella engineered to produce human cytokine LIGHT inhibit tumor growth. Proc Natl Acad Sci USA 104: 12879-12883.
22. Seow, Y and Wood, MJ (2009). Biological gene delivery vehicles: beyond viral vectors. Mol Ther 17: 767-777.
23. Nishikawa, H, Sato, E, Briones, G, Chen, LM, Matsuo, M, Nagata, Y et al. (2006). In vivo antigen delivery by a Salmonella typhimurium type III secretion system for therapeutic cancer vaccines. J Clin Invest 116: 1946-1954.
24. Pawelek, JM, Low, KB and Bermudes, D (1997). Tumor-targeted Salmonella as a novel anticancer vector. Cancer Res 57: 4537-4544.
25. Le, UN, Kim, HS, Kwon, JS, Kim, MY, Nguyen, VH, Jiang, SN et al. (2011). Engineering and visualization of bacteria for targeting infarcted myocardium. Mol Ther 19: 951-959.
26. Forbes, NS, Munn, LL, Fukumura, D and Jain, RK (2003). Sparse initial entrapment of systemically injected Salmonella typhimurium leads to heterogeneous accumulation within tumors. Cancer Res 63: 5188-5193.
27. Forbes, NS (2010). Engineering the perfect (bacterial) cancer therapy. Nat Rev Cancer 10: 785-794.
28. Loessner, H, Leschner, S, Endmann, A, Westphal, K, Wolf, K, Kochruebe, K et al. (2009). Drug-inducible remote control of gene expression by probiotic Escherichia coli Nissle 1917 in intestine, tumor and gall bladder of mice. Microbes Infect 11: 1097-1105.
29. Loessner, H, Endmann, A, Leschner, S, Westphal, K, Rohde, M, Miloud, T et al. (2007). Remote control of tumour-targeted Salmonella enterica serovar Typhimurium by the use of L-arabinose as inducer of bacterial gene expression in vivo. Cell Microbiol 9: 1529-1537.
30. Stritzker, J, Weibel, S, Hill, PJ, Oelschlaeger, TA, Goebel, W and Szalay, AA (2007). Tumor-specific colonization, tissue distribution, and gene induction by probiotic Escherichia coli Nissle 1917 in live mice. Int J Med Microbiol 297: 151-162.
31. Guzman, LM, Belin, D, Carson, MJ and Beckwith, J (1995). Tight regulation, modulation, and high-level expression by vectors containing the arabinose PBAD promoter. J Bacteriol 177: 4121-4130.
32. Royo, JL, Becker, PD, Camacho, EM, Cebolla, A, Link, C, Santero, E et al. (2007). In vivo gene regulation in Salmonella spp. by a salicylate-dependent control circuit. Nat Methods 4: 937-942.
33. Nuyts, S, Van Mellaert, L, Theys, J, Landuyt, W, Bosmans, E, Ann J et al. (2001). Radio-responsive recA promoter significantly increases TNFalpha production in recombinant clostridia after 2 Gy irradiation. Gene Ther 8: 1197-1201.
34. Nuyts, S, Van Mellaert, L, Barb? S, Lammertyn, E, Theys, J, Landuyt, W et al. (2001). Insertion or deletion of the Cheo box modifies radiation inducibility of Clostridium promoters. Appl Environ Microbiol 67: 4464-4470.
35. Williams, KJ, Joyce, G and Robertson, BD (2010). Improved mycobacterial tetracycline inducible vectors. Plasmid 64: 69-73.
36. Grkovic, S, Brown, MH and Skurray, RA (2002). Regulation of bacterial drug export systems. Microbiol Mol Biol Rev 66: 671-701, table of contents.
37. Gambhir, SS (2002). Molecular imaging of cancer with positron emission tomography. Nat Rev Cancer 2: 683-693.
38. Chang, HR, Comte, R and Pech?e, JC (1990). In vitro and in vivo effects of doxycycline on Toxoplasma gondii. Antimicrob Agents Chemother 34: 775-780.
39. Wai, SN, Lindmark, B, Serblom, T, Takade, A, Westermark, M, Oscarsson, J et al. (2003). Vesicle-mediated export and assembly of pore-forming oligomers of the enterobacterial ClyA cytotoxin. Cell 115: 25-35.
40. Loeffler, M, Le'Negrate, G, Krajewska, M and Reed, JC (2008). Inhibition of tumor growth using salmonella expressing Fas ligand. J Natl Cancer Inst 100: 1113-1116.
41. Westphal, K, Leschner, S, Jablonska, J, Loessner, H and Weiss, S (2008). Containment of tumor-colonizing bacteria by host neutrophils. Cancer Res 68: 2952-2960.
42. Kerrigan, JJ, Xie, Q, Ames, RS and Lu, Q (2011). Production of protein complexes via co-expression. Protein Expr Purif 75: 1-14.
43. Blau, HM and Rossi, FM (1999). Tet B or not tet B: advances in tetracycline-inducible gene expression. Proc Natl Acad Sci USA 96: 797-799.
44. Yang, S, Zhang, JJ and Huang, XY (2012). Mouse models for tumor metastasis. Methods Mol Biol 928: 221-228.
45. Zhao, M, Yang, M, Baranov, E, Wang, X, Penman, S, Moossa, AR et al. (2001). Spatialtemporal imaging of bacterial infection and antibiotic response in intact animals. Proc Natl Acad Sci USA 98: 9814-9818.
46. Hoffman, RM and Zhao, M (2006). Whole-body imaging of bacterial infection and antibiotic response. Nat Protoc 1: 2988-2994.
47. Lee, HJ and Hughes, KT (2006). Posttranscriptional control of the Salmonella enterica flagellar hook protein FlgE. J Bacteriol 188: 3308-3316.
48. Loening, AM, Fenn, TD, Wu, AM and Gambhir, SS (2006). Consensus guided mutagenesis of Renilla luciferase yields enhanced stability and light output. Protein Eng Des Sel 19: 391-400.
49. Song, M, Kim, HJ, Kim, EY, Shin, M, Lee, HC, Hong, Y et al. (2004). ppGpp-dependent stationary phase induction of genes on Salmonella pathogenicity island 1. J Biol Chem 279: 34183-34190.